Cargando…
Pharmacokinetic Principles and Their Application to Central Nervous System Tumors
Despite increasing knowledge of the biologic drivers of central nervous system tumors, most targeted agents trialed to date have not shown activity against these tumors in clinical trials. To effectively treat central nervous system tumors, an active drug must achieve and maintain an effective expos...
Autores principales: | Straehla, Joelle P., Warren, Katherine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601100/ https://www.ncbi.nlm.nih.gov/pubmed/33036139 http://dx.doi.org/10.3390/pharmaceutics12100948 |
Ejemplares similares
-
SURG-03. LAYER-BY-LAYER CORE-SHELL NANOPARTICLES FOR THE DELIVERY OF HDAC INHIBITORS TO THE CENTRAL NERVOUS SYSTEM
por: Marand, Michael H, et al.
Publicado: (2023) -
Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues
por: D’Agata, Federico, et al.
Publicado: (2017) -
Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
por: Warren, Katherine Elizabeth
Publicado: (2018) -
Applications of CRISPR/Cas9 in the Mammalian Central Nervous System
por: Savell, Katherine E., et al.
Publicado: (2017) -
Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems
por: Neumaier, Felix, et al.
Publicado: (2021)